FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2075428612> ?p ?o ?g. }

• W2075428612 endingPage "e102795" @default.
• W2075428612 startingPage "e102795" @default.
• W2075428612 abstract "Viral reservoirs-persistent residual virus despite combination antiretroviral therapy (cART)-remain an obstacle to cure of HIV-1 infection. Difficulty studying reservoirs in patients underscores the need for animal models that mimics HIV infected humans on cART. We studied SIV-infected Chinese-origin rhesus macaques (Ch-RM) treated with intensive combination antiretroviral therapy (cART) and 3 weeks of treatment with the histone deacetyalse inhibitor, suberoylanilide hydroxamic acid (SAHA).SIVmac251 infected Ch-RM received reverse transcriptase inhibitors PMPA and FTC and integrase inhibitor L-870812 beginning 7 weeks post infection. Integrase inhibitor L-900564 and boosted protease inhibitor treatment with Darunavir and Ritonavir were added later. cART was continued for 45 weeks, with daily SAHA administered for the last 3 weeks, followed by euthanasia/necropsy. Plasma viral RNA and cell/tissue-associated SIV gag RNA and DNA were quantified by qRT-PCR/qPCR, with flow cytometry monitoring changes in immune cell populations.Upon cART initiation, plasma viremia declined, remaining <30 SIV RNA copy Eq/ml during cART, with occasional blips. Decreased viral replication was associated with decreased immune activation and partial restoration of intestinal CD4+ T cells. SAHA was well tolerated but did not result in demonstrable treatment-associated changes in plasma or cell associated viral parameters.The ability to achieve and sustain virological suppression makes cART-suppressed, SIV-infected Ch-RM a potentially useful model to evaluate interventions targeting residual virus. However, despite intensive cART over one year, persistent viral DNA and RNA remained in tissues of all three animals. While well tolerated, three weeks of SAHA treatment did not demonstrably impact viral RNA levels in plasma or tissues; perhaps reflecting dosing, sampling and assay limitations." @default.
• W2075428612 created "2016-06-24" @default.
• W2075428612 creator A5012536969 @default.
• W2075428612 creator A5038299329 @default.
• W2075428612 creator A5043225490 @default.
• W2075428612 creator A5043773702 @default.
• W2075428612 creator A5069352807 @default.
• W2075428612 creator A5081063225 @default.
• W2075428612 creator A5088571596 @default.
• W2075428612 creator A5090958074 @default.
• W2075428612 date "2014-07-17" @default.
• W2075428612 modified "2023-09-26" @default.
• W2075428612 title "Effects of Treatment with Suppressive Combination Antiretroviral Drug Therapy and the Histone Deacetylase Inhibitor Suberoylanilide Hydroxamic Acid; (SAHA) on SIV-Infected Chinese Rhesus Macaques" @default.
• W2075428612 cites W1965266980 @default.
• W2075428612 cites W1979440146 @default.
• W2075428612 cites W1981459523 @default.
• W2075428612 cites W1993655001 @default.
• W2075428612 cites W1995389281 @default.
• W2075428612 cites W2004223360 @default.
• W2075428612 cites W2005141763 @default.
• W2075428612 cites W2014024977 @default.
• W2075428612 cites W2021707468 @default.
• W2075428612 cites W2027656718 @default.
• W2075428612 cites W2030987189 @default.
• W2075428612 cites W2037401972 @default.
• W2075428612 cites W2037913772 @default.
• W2075428612 cites W2047385553 @default.
• W2075428612 cites W2052959758 @default.
• W2075428612 cites W2054196192 @default.
• W2075428612 cites W2055796578 @default.
• W2075428612 cites W2062609352 @default.
• W2075428612 cites W2075345074 @default.
• W2075428612 cites W2077214173 @default.
• W2075428612 cites W2086674142 @default.
• W2075428612 cites W2095570051 @default.
• W2075428612 cites W2120014878 @default.
• W2075428612 cites W2137321682 @default.
• W2075428612 cites W2148835789 @default.
• W2075428612 cites W2149767613 @default.
• W2075428612 cites W2151940062 @default.
• W2075428612 cites W2163944364 @default.
• W2075428612 cites W2166861522 @default.
• W2075428612 cites W2168628698 @default.
• W2075428612 doi "https://doi.org/10.1371/journal.pone.0102795" @default.
• W2075428612 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4102539" @default.
• W2075428612 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/25033210" @default.
• W2075428612 hasPublicationYear "2014" @default.
• W2075428612 type Work @default.
• W2075428612 sameAs 2075428612 @default.
• W2075428612 citedByCount "17" @default.
• W2075428612 countsByYear W20754286122016 @default.
• W2075428612 countsByYear W20754286122017 @default.
• W2075428612 countsByYear W20754286122018 @default.
• W2075428612 countsByYear W20754286122019 @default.
• W2075428612 countsByYear W20754286122022 @default.
• W2075428612 crossrefType "journal-article" @default.
• W2075428612 hasAuthorship W2075428612A5012536969 @default.
• W2075428612 hasAuthorship W2075428612A5038299329 @default.
• W2075428612 hasAuthorship W2075428612A5043225490 @default.
• W2075428612 hasAuthorship W2075428612A5043773702 @default.
• W2075428612 hasAuthorship W2075428612A5069352807 @default.
• W2075428612 hasAuthorship W2075428612A5081063225 @default.
• W2075428612 hasAuthorship W2075428612A5088571596 @default.
• W2075428612 hasAuthorship W2075428612A5090958074 @default.
• W2075428612 hasBestOaLocation W20754286121 @default.
• W2075428612 hasConcept C140704245 @default.
• W2075428612 hasConcept C142462285 @default.
• W2075428612 hasConcept C159047783 @default.
• W2075428612 hasConcept C203014093 @default.
• W2075428612 hasConcept C2522874641 @default.
• W2075428612 hasConcept C2776185481 @default.
• W2075428612 hasConcept C2776202225 @default.
• W2075428612 hasConcept C2777302000 @default.
• W2075428612 hasConcept C2777995582 @default.
• W2075428612 hasConcept C2778305200 @default.
• W2075428612 hasConcept C2779182219 @default.
• W2075428612 hasConcept C2779298103 @default.
• W2075428612 hasConcept C2781143361 @default.
• W2075428612 hasConcept C2993143319 @default.
• W2075428612 hasConcept C54355233 @default.
• W2075428612 hasConcept C552990157 @default.
• W2075428612 hasConcept C64927066 @default.
• W2075428612 hasConcept C71924100 @default.
• W2075428612 hasConcept C86803240 @default.
• W2075428612 hasConcept C8891405 @default.
• W2075428612 hasConceptScore W2075428612C140704245 @default.
• W2075428612 hasConceptScore W2075428612C142462285 @default.
• W2075428612 hasConceptScore W2075428612C159047783 @default.
• W2075428612 hasConceptScore W2075428612C203014093 @default.
• W2075428612 hasConceptScore W2075428612C2522874641 @default.
• W2075428612 hasConceptScore W2075428612C2776185481 @default.
• W2075428612 hasConceptScore W2075428612C2776202225 @default.
• W2075428612 hasConceptScore W2075428612C2777302000 @default.
• W2075428612 hasConceptScore W2075428612C2777995582 @default.
• W2075428612 hasConceptScore W2075428612C2778305200 @default.
• W2075428612 hasConceptScore W2075428612C2779182219 @default.
• W2075428612 hasConceptScore W2075428612C2779298103 @default.
• W2075428612 hasConceptScore W2075428612C2781143361 @default.

• next